Endo International plc (ENDP)

9.43 -0.01 (-0.106%)

IEX Real-Time Price

June 20, 2018 EST.

Nasdaq Global Select : Healthcare

Prev Close 9.44

Price Open 9.38

Volume: 5.11M

Avg Volume: 7.58M

Market Cap: 2.11B

P/E Ratio 2.87

52 Wk Range 5.27-12.54



ENDP Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-05-31
217.12M
37.59M
7.81
17.31%

2018-05-15
216.83M
33.09M
6.90
15.26%

2018-04-30
219.09M
32.21M
7.38
14.70%

2018-04-13
218.64M
33.79M
6.99
15.46%




ENDP Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-05-08
Q1 2018
N/A
0.54 (10)
0.00
0.00

2018-02-27
Q4 2017
N/A
0.62 (8)
0.77
0.15

2017-11-09
Q3 2017
AMC
0.85 (2)
0.77
0.15

2017-08-08
Q2 2017
BTO
0.74 (9)
0.77
0.15

News

Your Daily Pharma Scoop: Tetraphase Positive Data, MediWound In Phase 3, Allergan Moves Up (2018-06-13 18:00 SeekingAlpha)

Analysis Focus: TTPH Tetraphase Pharma ( TTPH ) has a PDUFA on August 28 for its lead drug candidate ERAVACYCLINE in one indication - cIAI - complicated intra-abdominal infections. This PDUFA is based on an NDA filed on Feb 27 - the 6-month duration comes from a Fast Track designation; the…

 

Buy Alibaba - Cramer's Lightning Round (6/12/18) (2018-06-13 07:07 SeekingAlpha)

Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Tuesday, June 12. Bullish Calls Applied Materials (AMAT): It's okay to buy here, but Cramer did not pound the table. Endo International (ENDP): Cramer likes the generic drug stocks, including Mylan (MYL)…

 


Statistics

Shares Outstanding: 223.79M

Top 15 Institution Percent: 93.90

Price To Sales: 0.65

Price To Book: 2.64

Revenue: 1.66B

Gross Profit: 608.70M

Cash: 1.35B

Debt: 16.57B

Return On Assets: -18.05

Return On Equity: -187.50

Profit Margin: -75.25

Price History

Beta: 0.53

50-day Moving Avg: 6.43

200-day Moving Avg: 7.14

YTD Change: 16.54

5-day Change: 6.31

1-month Change: 58.12

3-month Change: 40.69

6-month Change: 15.69

1-year Change: -14.57

Revenue Per Share: 7.00

Revenue Per Employee: 547094.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Endo International plc

Exchange: Nasdaq Global Select

Industry: Drug Manufacturers

Sector: Healthcare

Website: http://www.endo.com

Endo International PLC is a generics and specialty branded pharmaceutical company. The company sells generic products in the US which includes pain management, urology, central nervous system disorders, immunosuppression, and oncology and among others.